Nitrofurantoin Pharmsol

Nitrofurantoin, the active ingredient in Nitrofurantoin Pharmsol, is a nitrofuran antibiotic presented as an oral dosage form for oral use. It is employed to treat uncomplicated urinary tract infections in adult patients, targeting susceptible bacteria within the urinary tract and helps to alleviate associated symptoms such as dysuria and frequency while minimizing systemic exposure.

GNH USA supplies Nitrofurantoin Pharmsol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with reliable quality assurance and on‑time delivery across multiple regions.

Nitrofurantoin is indicated for bacterial infections of the urinary tract, particularly uncomplicated infections.

Uncomplicated urinary tract infection: eliminates the causative bacteria and resolves infection symptoms. Acute cystitis: provides targeted antibacterial activity within the bladder, reducing inflammation and discomfort. Prophylaxis of recurrent urinary tract infections: reduces the frequency of future episodes when used as a preventive regimen.

Nitrofurantoin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Loss of appetite - Headache - Diarrhea

Serious or Rare Side Effects: - Pulmonary toxicity (interstitial pneumonitis or fibrosis) - Hepatic injury (elevated enzymes, hepatitis) - Severe allergic reactions, including Stevens‑Johnson syndrome and toxic epidermal necrolysis

When prescribing Nitrofurantoin Pharmsol, several safety considerations are recommended.

Renal function assessment: avoid use in patients with creatinine clearance below 60 mL/min. Pregnancy consideration: prescribe only if clearly needed, as safety data are limited. G6PD deficiency: contraindicated due to risk of hemolysis. Drug interaction review: evaluate concomitant medications that may affect absorption or excretion. Patient counseling: advise completion of full prescribed course even if symptoms improve. Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Nitrofurantoin may interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce nitrofurantoin absorption. - Probenecid: decreases urinary excretion, lowering efficacy. - Warfarin: may potentiate anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - Trimethoprim‑sulfamethoxazole: additive nephrotoxicity risk. - Fluoroquinolones: combined use may increase tendon rupture risk. - Diuretics: may raise urinary concentration of nitrofurantoin, enhancing side effects.